Acute Ischaemic Stroke Clinical Trial
Official title:
Magnetic Resonance Post-contrast Vascular Hyperintensities at 3 T: a New Highly Sensitive Sign of Vascular Occlusion in Acute Ischaemic Stroke
Verified date | May 2019 |
Source | Fondation Ophtalmologique Adolphe de Rothschild |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
Magnetic resonance imaging (MRI) is the diagnostic cornerstone for precisely identifying
acute ischaemic strokes and locating vascular occlusions.
It was observed that a post-contrast three-dimensional turbo-spin-echo T1weighted sequence
showed striking post-contrast vascular hyperintensities (PCVH) in ischaemic territories. The
aim is to evaluate the prevalence and the meaning of this finding.
This study included 130 consecutive patients admitted for acute ischaemic stroke with a 3-T
MRI performed in the first 12 h of symptom onset from September 2014 through September 2016.
Two neuroradiologists blinded to clinical data analysed the first MRI assessments.
Status | Completed |
Enrollment | 130 |
Est. completion date | September 1, 2016 |
Est. primary completion date | September 1, 2016 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion criteria: - Patients aged 18 and older at onset of an acute ischaemic stroke - Availability of at least one pre-therapeutic MRI performed in our centre within 12 h of stroke onset, including a post-contrast 3D TSE T1-weighted sequence. Exclusion criteria: - Patients with posterior fossa strokes - Patients with known intracranial vasculitis or MoyaMoya disease - Presence of severe MR imaging artefacts preventing correct interpretation |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Fondation Ophtalmologique Adolphe de Rothschild |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | overal survival | from the AR-PML diagnosis date to that of death or censored on 31 December 2015 | 7 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT03463551 -
Perfluorocarbon (ABL-101) Oxygenation for Stroke: Trial With GOLD (Glasgow Oxygen Level Dependent Technology) Imaging Theranostic
|
Phase 2 | |
Completed |
NCT02164357 -
Efficacy and Security of an Endovascular Treatment as First Choice Procedure Compared With a Standard Intravenous Thrombolytic Therapy Treatment for Patients With Acute Ischemic Stroke Within 4.5 Hours After Onset
|
N/A | |
Recruiting |
NCT01207336 -
Combined tDCS+PNS After Acute Stroke
|
Phase 2/Phase 3 | |
Completed |
NCT03328403 -
Endovascular Therapy in Acute Ischaemic Stroke Due to Large Vessel Occlusion
|
N/A | |
Recruiting |
NCT06379464 -
Screening of New Markers of Gut Microbiota in Stroke and Depression: a Cross-sectional Study
|
||
Recruiting |
NCT03639922 -
Imatinib in Acute Ischaemic Stroke
|
Phase 3 | |
Completed |
NCT03865225 -
Effects of Heart Rate Variability Biofeedback in Patients With Acute Ischemic Stroke
|
N/A | |
Completed |
NCT03541668 -
Study of rhPro-UK in Patients With Acute Ischaemic Stroke in 4.5 Hours After Stroke Onset(PROST)
|
Phase 3 | |
Completed |
NCT03354429 -
THALES - Acute STroke or Transient IscHaemic Attack Treated With TicAgreLor and ASA for PrEvention of Stroke and Death
|
Phase 3 | |
Completed |
NCT01994720 -
[SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]
|
Phase 3 | |
Terminated |
NCT01745692 -
Pragmatic Ischaemic Stroke Thrombectomy Evaluation
|
N/A | |
Completed |
NCT03578822 -
Thrombolysis With rhPro-UK in 4.5-6 Hours After Acute Ischemic Stroke in a Double-blinded,Controlled Trial
|
Phase 3 |